search
epilepsy
Trends
- 1Frequent cannabis use linked to more severe epilepsy▼Frequent cannabis use tied to more severe epilepsy
Researchers at Washington University School of Medicine report that people who use cannabis frequently tend to have more severe epilepsy. The finding, covered by Medical Xpress, suggests heavy marijuana use is associated with worse seizure outcomes, though the relationship between cannabis and epilepsy remains an active area of debate in medical research.
- 2Pharmacogenomics Advances Personalized Epilepsy Treatment▼The role of pharmacogenomics in epilepsy treatment: advancements in personalized medicine
A new discussion highlights how pharmacogenomics — using a patient's genetic profile to guide drug selection and dosing — is reshaping epilepsy care. By identifying genetic variants that affect drug response and the risk of severe side effects, clinicians hope to move away from trial-and-error prescribing toward tailored treatment plans that control seizures faster and more safely.
- 3Ketogenic Metabolic Therapy Explored for Serious Mental Illness▼Potential of Ketogenic Metabolic Therapy as an Adjunct in Serious Mental Illness
Psychiatric Times reports on the potential of ketogenic metabolic therapy as an adjunct treatment for serious mental illness. The article examines how a ketogenic diet, already used for epilepsy, may help address metabolic dysfunction linked to conditions such as schizophrenia and bipolar disorder when combined with standard psychiatric care, while clinicians weigh the evidence and practical challenges of dietary interventions in mental health treatment.
- 4Ketogenic diet therapy shows promise for treating mental illness▼Research shows promising results for health care professionals using ketogenic diet therapy to treat mental illness
New research reports promising results for health care professionals using ketogenic diet therapy to treat mental illness. The findings suggest the high-fat, low-carbohydrate diet, long known for epilepsy treatment, may benefit patients with psychiatric conditions when used under medical supervision. The news is drawing attention from clinicians and nutrition researchers, who say further trials will be needed to confirm the results.